tiprankstipranks
Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh (BR:BMYB34)
:BMYB34
Brazil Market
BMYB34
Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh
RESEARCH TOOLSreports

Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh (BMYB34) Price & Analysis

― Followers

BMYB34 Stock Chart & Stats

R$337.00
R$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeR$100.00 - R$337.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)28.00
Market Cap
R$677.18B
Enterprise ValueR$791.44K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13671.4
Beta-0.35
Next Earnings
Oct 29, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,042,714,600
10 Day Avg. Volume25
30 Day Avg. Volume28
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh News

Midday Fly By: SpaceX slips, Disney reports earnings beat
Midday Fly By: SpaceX slips, Disney reports earnings beat
The major averages were mixed near noon, with the Dow up nearly 400 points as investors weigh another...
2d ago
BX
MS
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here...
2d ago
AZN
BBY
Bristol Myers upgraded to Buy from Hold at Argus
Bristol Myers upgraded to Buy from Hold at Argus
Argus analyst Jasper Hellweg upgraded Bristol Myers (BMY) to Buy from Hold with a $75 price target Bristol...
2d ago
BMY
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
AstraZeneca (AZN) and Bristol Myers (BMY) are not engaged in merger discussions, ending speculation around a potential $400B...
2d ago
AZN
BMY
Schrodinger announces collaboration, software agreement with Bristol Myers
Schrodinger announces collaboration, software agreement with Bristol Myers
Schrodinger (SDGR) announced a strategic agreement with Bristol Myers Squibb (BMY) to deploy Bunsen, Schrodinger’s agentic AI co-scientist,...
2d ago
BMY
SDGR
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
AstraZeneca’s (AZN) merger talks with Bristol Myers (BMY) remain active, Liz Hoffman of Semafor reports. A potential deal...
3d ago
AZN
BMY
TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger
TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger
TD Cowen analyst Steve Scala doesn’t see logic in combination of AstraZeneca (AZN) and Bristol Myers (BMY). If...
4d ago
AZN
BMY
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
The major averages were sharply higher near noon, with traders approaching the new month with a sense of...
4d ago
L
TT
Morning Movers: Supernus and Indivior jump following merger pact
Morning Movers: Supernus and Indivior jump following merger pact
Stock futures are higher as investors begin a new month with improving risk appetite after easing tensions in...
4d ago
AZN
BMY
Video: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
Video: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how...
4d ago
AZN
BMY
Bristol-Myers Squibb: Strong Q2 Beat, Intact Pipeline Support Buy Rating as Jason Gerberry Raises Price Target from $66 to $71
Bristol-Myers Squibb: Strong Q2 Beat, Intact Pipeline Support Buy Rating as Jason Gerberry Raises Price Target from $66 to $71
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Bristol-Myers Squibb yesterday and set a...
7d ago
BMY
Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating
Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating
William Blair analyst Matt Phipps has maintained their neutral stance on BMY stock, giving a Hold rating on...
8d ago
BMY

BMYB34 FAQ

What was Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s price range in the past 12 months?
Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh lowest stock price was R$100.00 and its highest was R$337.50 in the past 12 months.
    What is Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s market cap?
    Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s market cap is R$677.18B.
      When is Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s upcoming earnings report date?
      Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s upcoming earnings report date is Oct 29, 2026 which is in 83 days.
        How were Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s earnings last quarter?
        Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh released its earnings results on Jul 30, 2026. The company reported R$0.008 earnings per share for the quarter, beating the consensus estimate of N/A by R$0.008.
          Is Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh overvalued?
          According to Wall Street analysts Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh pay dividends?
            Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh does not currently pay dividends.
            What is Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s EPS estimate?
            Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh have?
            Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh has 2,042,714,600 shares outstanding.
              What happened to Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh’s price movement after its last earnings report?
              Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh reported an EPS of R$0.008 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.04%.
                Which hedge fund is a major shareholder of Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh?
                Currently, no hedge funds are holding shares in BR:BMYB34
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh (BMYB34) Earnings & Revenues

                  Historic Earnings Reports
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  ABTT34
                  Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S
                  ―
                  ―
                  GILD34
                  Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh
                  ―
                  ―
                  PFIZ34
                  Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh
                  ―
                  ―
                  REGN34
                  Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh
                  ―
                  ―
                  VRTX34
                  Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh
                  ―
                  ―
                  Compare BR:BMYB34 Stocks >
                  Popular Stocks